StockTipsArenaBeta

BUY Aurobindo Pharma — Pradip Hotchandani, Prudent Corporate Advisory Services

BUYAurobindo Pharma

byPradip Hotchandani, Prudent Corporate Advisory ServicesHorizon: NA (inferred Swing (≤2wk))30 Mar 2026via CNBC Awaaz.

Entry₹1,315Stated
Target₹1,380
Total upside +4.94% (call closed)
Stop loss₹1,273-3.19% risk
Exit₹1,2732 Apr 2026, 9:45 am
Stop-loss hit-3.19%
Follow Pradip Hotchandani for new calls(22% target hit, 37 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 4 active Swing calls on AUROPHARMASee 274 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Apr 2026
1 supporting0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·1 Apr · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.